These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4867941)

  • 1. Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration.
    DasGupta BR; Boroff DA
    J Biol Chem; 1968 Mar; 243(5):1065-72. PubMed ID: 4867941
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of chromatographically pure toxin of Clostridium botulinum type B.
    DasGupta BR; Boroff DA; Cheong K
    Biochem Biophys Res Commun; 1968 Sep; 32(6):1057-63. PubMed ID: 4882877
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromatographic isolation of hemagglutinin-free neurotoxin from crystalline toxin of Clostridium botulinum type A.
    DasGupta BR; Boroff DA
    Biochim Biophys Acta; 1967 Dec; 147(3):603-5. PubMed ID: 4866586
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study of botulin toxins and anatoxins by the gel filtration method. II. Separation of native type A botulin toxins by filtration through Sephadex G-200 gel].
    Freĭman VB; Golshmid VK; Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):106-9. PubMed ID: 4891690
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.
    Dasgupta BR; Boroff DA; Rothstein E
    Biochem Biophys Res Commun; 1966 Mar; 22(6):750-6. PubMed ID: 5329438
    [No Abstract]   [Full Text] [Related]  

  • 6. Homogeneity and molecular weight of toxin of Clostridium botulinum type B.
    Boroff DA; Dasgupta BR; Fleck US
    J Bacteriol; 1968 May; 95(5):1738-44. PubMed ID: 4967772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic purification of the toxin of type E Clostridium botulinum.
    Emodi AS; Lechowich RV
    Biochem Biophys Res Commun; 1969 Jun; 35(6):788-95. PubMed ID: 4893076
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and characterization of Clostridium botulinum type B toxin.
    Beers WH; Reich E
    J Biol Chem; 1969 Aug; 244(16):4473-9. PubMed ID: 4896752
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of Clostridium botulinum type A toxin.
    Dasgupta BR; Berry LJ; Boroff DA
    Biochim Biophys Acta; 1970 Aug; 214(2):343-9. PubMed ID: 4993506
    [No Abstract]   [Full Text] [Related]  

  • 10. PURIFICATION AND MOLECULAR WEIGHT DETERMINATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN.
    GERWING J; DOLMAN CE; REICHMANN ME; BAINS HS
    J Bacteriol; 1964 Jul; 88(1):216-9. PubMed ID: 14197891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation studies on the toxin of Clostridium botulinum type B.
    Mitchell B; Gerwing J
    Biochim Biophys Acta; 1969 May; 181(1):336-8. PubMed ID: 4893322
    [No Abstract]   [Full Text] [Related]  

  • 12. COMPARATIVE GEL FILTRATION OF TOXIN PRECURSOR AND TRYPSIN-ACTIVATED TOXIN OF CLOSTRIDIUM BOTULINUM TYPE E.
    SAKAGUCHI G; SAKAGUCHI S; IMAI N
    J Bacteriol; 1964 Feb; 87(2):401-7. PubMed ID: 14151063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MECHANISM OF TRYPTIC ACTIVATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN.
    GERWING J; DOLMAN CE; KO A
    J Bacteriol; 1965 May; 89(5):1176-9. PubMed ID: 14292982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that botulinum C2 toxin has two dissimilar components.
    Iwasaki M; Ohishi I; Sakaguchi G
    Infect Immun; 1980 Aug; 29(2):390-4. PubMed ID: 7011974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation and reconstitution of 12-S toxin of Clostridium botulinum type E.
    Kitamura M; Sakaguchi G
    Biochim Biophys Acta; 1969 Dec; 194(2):564-71. PubMed ID: 4983702
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular size of Clostridium botulinum type E toxin in "izushi".
    Sakaguchi G; Sakaguchi S; Karashimada T
    Jpn J Med Sci Biol; 1966 Aug; 19(4):201-7. PubMed ID: 5332600
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISOLATION AND CHARACTERIZATION OF A TOXIC MOIETY OF LOW MOLECULAR WEIGHT FROM CLOSTRIDIUM BOTULINUM TYPE A.
    GERWING J; DOLMAN CE; BAINS HS
    J Bacteriol; 1965 May; 89(5):1383-6. PubMed ID: 14293025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.